Oxford Biodynamics Plc (Oxford Biodynamics) is a biotech company that specializes in the development and commercialization of precision medicine tests for various diseases. The company's products include EpiSwitch. Its EpiSwitch biomarker discovery platform is used for the detection of aberrant gene expressions. The company's products are used in the areas of breast cancer diagnostics, hepatocellular carcinoma diagnostics, nasopharyngeal carcinoma diagnostics, prostate cancer progression, melanoma diagnostics and age-related disease diagnostics. The company has its presence in the UK, the US, and Malaysia. Oxford Biodynamics is headquartered in Oxford, Oxfordshire, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Oxford Biodynamics Plc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Oxford Biodynamics Plc Company Overview
Oxford Biodynamics Plc Company Snapshot
Oxford Biodynamics Plc Pipeline Products and Ongoing Clinical Trials Overview
EpiSwitch Prostate Cancer Prognostic Assay Product Overview
EpiSwitch Relapsing Remitting Multiple Sclerosis Test
EpiSwitch Relapsing Remitting Multiple Sclerosis Test Product Overview
EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test
EpiSwitch Rheumatoid Arthritis Predictive Biomarker Test Product Overview
EpiSwitch Systemic Lupus Erythematosus Prognostic Test
EpiSwitch Systemic Lupus Erythematosus Prognostic Test Product Overview
EpiSwitch T1DM Diagnostic Test
EpiSwitch T1DM Diagnostic Test Product Overview
EpiSwitch T1DM Prognostic Test
EpiSwitch T1DM Prognostic Test Product Overview
EpiSwitch T2DM Prognostic Test
EpiSwitch T2DM Prognostic Test Product Overview
EpiSwitch Test - Huntington's Disease
EpiSwitch Test - Huntington's Disease Product Overview
EpiSwitch Thyroid Cancer Diagnostic Test
EpiSwitch Thyroid Cancer Diagnostic Test Product Overview
EpiSwitch Ulcerative Colitis Test
EpiSwitch Ulcerative Colitis Test Product Overview
Oxford Biodynamics Plc - Key Competitors
Oxford Biodynamics Plc - Key Employees
Oxford Biodynamics Plc - Locations And Subsidiaries
Head Office
Recent Developments
Oxford Biodynamics Plc, Recent Developments
Jun 25, 2024: Oxford BioDynamics part of consortium shortlisted for Strategic Government Initiative to Improve Cancer Immunotherapy
Jun 06, 2024: Oxford BioDynamics Announces EpiSwitch Prostate Screening (PSE) Blood Test to be used in correlative studies of NCI Trial for Prospective Monitoring of Biochemically Recurrent Prostate Cancer
May 23, 2024: Oxford BioDynamics Partners With Goodbody Clinic To Offer Nationwide Access to the EpiSwitch PSE test
May 21, 2024: Oxford Biodynamics Partners With the London Clinic To Offer Episwitch PSE and Cirt Oncology Tests
May 16, 2024: Oxford Biodynamics and King’s College London Collaborate to Develop EpiSwitch Prognostic and Predictive Biomarkers for Best Prevention of Rheumatoid Arthritis Following the APIPPRA Trial
Apr 03, 2024: Oxford Biodynamics opens clinical testing facility in the UK to perform EpiSwitch Prostate Screening (PSE) blood test
Nov 08, 2023: Oxford Biodynamics Strengthens Commercial Leadership With New SVP of Business and Corporate Development
Oct 03, 2023: Oxford Biodynamics Receives Reimbursement Code for Episwitch Prostate Screening (PSE) Test
Sep 26, 2023: Oxford Biodynamics Announces US Launch of its 94% Accurate EpiSwitch Prostate Screening Blood Test to Men With Prostate Cancer Risk
May 16, 2023: Oxford BioDynamics notice of interim results and investor webinar
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Oxford Biodynamics Plc Pipeline Products and Ongoing Clinical Trials Overview
Oxford Biodynamics Plc Pipeline Products by Equipment Type
Oxford Biodynamics Plc Pipeline Products by Indication
Oxford Biodynamics Plc Ongoing Clinical Trials by Trial Status
Oxford Biodynamics Plc, Key Facts
Oxford Biodynamics Plc, Major Products and Services
Oxford Biodynamics Plc Number of Pipeline Products by Development Stage
Oxford Biodynamics Plc Pipeline Products Summary by Development Stage
Oxford Biodynamics Plc Ongoing Clinical Trials by Trial Status